Record ID | marc_records_scriblio_net/part23.dat:147495230:1474 |
Source | Scriblio |
Download Link | /show-records/marc_records_scriblio_net/part23.dat:147495230:1474?format=raw |
LEADER: 01474nam 2200325 a 4500
001 93106995
003 DLC
005 19990716000000.0
008 930125s1992 dcua b f000 0 eng c
010 $a 93106995
020 $a0160383811
040 $aDGPO/DLC$cDLC
043 $an-us---
050 00 $aKF27$b.G663 1991e
082 00 $a362.1/78/0973$220
086 0 $aY 4.G 74/7:D 84/30
110 1 $aUnited States.$bCongress.$bHouse.$bCommittee on Government Operations.$bHuman Resources and Intergovernmental Relations Subcommittee.
245 10 $aPromotion of drugs and medical devices for unapproved uses :$bhearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
260 $aWashington :$bU.S. G.P.O. :$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$c1992.
300 $aiv, 395 p. :$bill. ;$c24 cm.
500 $aItem 1016-A, 1016-B (MF)
500 $aDistributed to some depository libraries in microfiche.
500 $aShipping list no.: 92-273-P.
504 $aIncludes bibliographical references.
650 0 $aDrugs$xGovernment policy$zUnited States.
650 0 $aMedical instruments and apparatus$xGovernment policy$zUnited States.
650 0 $aTretinoin.
650 0 $aCollagen.
650 0 $aSilicones in surgery.
610 10 $aUnited States.$bFood and Drug Administration.